Table 1.
Effects of soy product consumption on liver related outcomes in adults with NAFLD.
| Country | N | Intervention | Duration * (wk) | Key Liver Outcomes | Ref. |
|---|---|---|---|---|---|
| Iran | 45 | 30 g soy nut | 8 | Reduced ALT and AST levels | [116] |
| Iran | 70 | 240 mL soy milk | 8 | Reduced ALT, no change in fatty liver grade or AST, GGT, ALP levels | [112] |
| Germany | 22 | Soy meal replacement (83% soy protein isolate) | 24 | Reduced ALT and liver fat, but not different from the lifestyle modification control group | [118] |
* Duration is shown in weeks. Abbreviations: ALP: alkaline phosphatase; ALT: alanine transaminase; AST: aspartate transaminase; GGT: gamma-glutamyltransferase.